The Situation
A top pharmaceutical company needed to remain continuously informed of key market and competitive developments in the U.S. acute migraine space, with particular emphasis on marketed competitors. Beyond tactical monitoring, the client sought a partner that could provide deeper analysis, strategic context, and forward-looking implications to inform commercial and portfolio decision-making.
The Solution
Sedulo implemented a robust competitive monitoring and intelligence program anchored in deep therapeutic expertise and continuous primary and secondary research.
- Ongoing Competitive Monitoring
Sedulo conducted ongoing secondary research and targeted primary intelligence focused on high-priority Key Intelligence Topics and Questions defined in collaboration with the client. The program emphasized commercial, regulatory, and clinical activity for marketed competitors, with analysis of potential impact to the client.
- Real-Time Flash Alerts
As high-priority insights emerged, Sedulo delivered immediate email flash alerts to ensure stakeholders had immediate visibility into critical developments.
- Quarterly Landscape Updates
Sedulo delivered four executive-ready quarterly landscape reports synthesizing current findings, insights, and implications. Each update included an executive dashboard, comprehensive analysis aligned to priority questions, categorized primary research findings, data visualization, and documentation of collection methodology.
The Impact
The client gained a continuously updated, high-confidence view of the acute migraine competitive landscape in the U.S., along with clear strategic implications. Sedulo’s program enabled faster response to competitor moves, stronger commercial planning, and a more proactive approach to managing risk and opportunity in a dynamic market.
